These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9116914

  • 1. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
    Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A.
    Eur J Endocrinol; 1997 Feb; 136(2):188-95. PubMed ID: 9116914
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
    Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
    Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.
    Jääskeläinen J, Voutilainen R.
    Pediatr Res; 1997 Jan; 41(1):30-3. PubMed ID: 8979286
    [Abstract] [Full Text] [Related]

  • 9. Compromised Adult Height in Females with Non-Classical Congenital Adrenal Hyperplasia Diagnosed in Childhood.
    Bello R, Lazar L, Phillip M, de Vries L.
    Horm Res Paediatr; 2023 Jan; 96(5):465-472. PubMed ID: 36806217
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF, McNeill E, Young D, Donaldson MD.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
    Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM.
    Arch Dis Child; 2002 Aug; 87(2):139-44. PubMed ID: 12138066
    [Abstract] [Full Text] [Related]

  • 16. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
    J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
    [Abstract] [Full Text] [Related]

  • 17. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.
    J Clin Endocrinol Metab; 2001 Sep 01; 86(9):4127-32. PubMed ID: 11549638
    [Abstract] [Full Text] [Related]

  • 18. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W, Schwarz HP.
    Horm Res Paediatr; 2011 Sep 01; 75(4):264-8. PubMed ID: 21196707
    [Abstract] [Full Text] [Related]

  • 19. Long-term Growth in Congenital Adrenal Hyperplasia.
    Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
    Indian J Pediatr; 2019 Feb 01; 86(2):154-158. PubMed ID: 30097840
    [Abstract] [Full Text] [Related]

  • 20. Initial high dose hydrocortisone (HDC) treatment for 21-hydroxylase deficiency (21-OHD) does not affect linear growth during the first three years of life.
    Takasawa K, Ono M, Miyai K, Matsubara Y, Takizawa F, Onishi T, Kashimada K, Mizutani S.
    Endocr J; 2012 Feb 01; 59(11):1001-6. PubMed ID: 22785554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.